Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health (NIH) is an agency operating within the Department of Human Health and Services and is responsible for the country's bio-medical and health-related research studies.

The NIH's efforts are mainly focused on obtaining new information to help prevent, detect, diagnose and treat a wide range of diseases and disabilities, all in the hopes of uncovering new knowledge that will lead to a better health for all.

In keeping with its goals and objectives, NIH has recently established a program entitled Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments.

The goal of the Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments program is to be able to seek high-quality, health economics research ancillary to large-scale federal and non-federal pilots, demonstrations, other experiments in areas of health care payment, structure, or health care organization that are currently seeking approaches that would reduce costs while simultaneously enhancing quality and outcomes.

As emphasized in the program's official announcement, the types of research that are encouraged may include:

a) Research studies that would boost the scientific yield of completed or ongoing Pilots, Demonstrations, and Other Experiments (PDEs)

b) Research studies that would improve the scientific yield of multi-site PDEs

c) Research studies that would formally test the effect of costs, quality, and patient outcomes of PDEs that have been the subject of less rigorous analyses.

  (continued...)

Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Rheumatic Diseases Research Core Centers Project
The National Institutes of Health, in close cooperation with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), has established a program entitled Rheumatic Diseases Research Core Centers Project wherein they intend to solicit applications for the development of Research Core Centers concentrating on rheumatic diseases.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Health Resources and Services Administration's Licensure Portability Grant Program
The Health Resources and Services Administration has constituted the Licensure Portability Grant Program (LPGP) wherein they aim to improve the experience of State licensing boards that have manifested a credible record in implementing cross-border activities in order to help overcome licensure barriers in the provision of telemedicine services across various States.

---

Exploratory Clinical Trials for Small Business Grant Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they aim to establish a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NIND

---